patent/DE-602005000187-D1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-602005000187-D1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
filingDate	2005-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5093ccb0feba5847945e64dc749931e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5c79ee99565f9ce4e0f3c7c073f9c14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_774d189aac99e5c784968f306eaca4ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e05242e843ddbbaa8eb86b74f0c8c2a6
publicationDate	2006-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	DE-602005000187-D1
titleOfInvention	Process for the preparation of (1S) -4,5-dimethoxy-1- (methylaminomethyl) -benzocyclobutane and its acid addition salts, and their use for the synthesis of ivabradine and their acid addition salts of pharmaceutically acceptable acid
priorityDate	2004-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132999 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420107209 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11499437 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536366

Total number of triples: 33.